• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受静脉-静脉血液透析滤过治疗患者的环丙沙星血药浓度

Ciprofloxacin levels in a patient undergoing veno-venous haemodiafiltration.

作者信息

Barrie J R, Mousdale S

机构信息

Department of Anaesthetics, Withington Hospital, West Didsbury, Manchester, UK.

出版信息

Intensive Care Med. 1992;18(7):437-8. doi: 10.1007/BF01694350.

DOI:10.1007/BF01694350
PMID:1469186
Abstract

Haemofiltration is a popular technique for removal of fluid and small to medium size molecules in critically ill patients. Whilst there is often good information on drug disposition in chronic renal failure, there is a lack of information available to guide Intensivists on how to prescribe drugs in patients in acute renal failure undergoing haemofiltration or haemodiafiltration.

摘要

血液滤过是一种用于清除危重症患者体内液体和中小分子的常用技术。虽然关于慢性肾衰竭患者药物处置的信息通常较为充分,但缺乏相关信息来指导重症监护医生如何为接受血液滤过或血液透析滤过的急性肾衰竭患者开药。

相似文献

1
Ciprofloxacin levels in a patient undergoing veno-venous haemodiafiltration.接受静脉-静脉血液透析滤过治疗患者的环丙沙星血药浓度
Intensive Care Med. 1992;18(7):437-8. doi: 10.1007/BF01694350.
2
Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.环丙沙星在接受持续静脉-静脉血液透析滤过的重症监护病房患者中的药代动力学。
Intensive Care Med. 2001 Apr;27(4):665-72. doi: 10.1007/s001340100857.
3
Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.急性肾衰竭患者在接受持续静脉-静脉血液滤过治疗时环丙沙星的药代动力学:合并肝硬化的影响
Acta Med Austriaca. 2002;29(3):112-6. doi: 10.1046/j.1563-2571.2002.02017.x.
4
Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.比较连续静脉-静脉血液滤过和血液透析滤过在危重症患者中对环丙沙星群体药代动力学的影响。
J Antimicrob Chemother. 2016 Jun;71(6):1643-50. doi: 10.1093/jac/dkw043. Epub 2016 Mar 7.
5
A service evaluation comparing CVVH an CVVHD in minimising circuit failure.一项比较连续性静脉-静脉血液滤过(CVVH)和连续性静脉-静脉血液透析滤过(CVVHD)在减少体外循环失败方面的服务评估。
Nurs Crit Care. 2017 Jan;22(1):52-57. doi: 10.1111/nicc.12230. Epub 2016 Feb 12.
6
Dosage of intravenous ciprofloxacin.
J Antimicrob Chemother. 1987 Sep;20(3):454-6. doi: 10.1093/jac/20.3.454.
7
Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
Contrib Nephrol. 2004;144:317-28. doi: 10.1159/000078899.
8
Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.急性肺部加重期的小儿囊性纤维化患者中序贯静脉注射/口服环丙沙星的药代动力学处置情况。
Pediatr Infect Dis J. 1997 Jan;16(1):112-7; discussion 123-6. doi: 10.1097/00006454-199701000-00033.
9
The use of propofol for sedation of critically ill patients undergoing haemodiafiltration.
Intensive Care Med. 1995 Apr;21(4):342-7. doi: 10.1007/BF01705413.
10
[Dosage of antipseudomonal antibiotics in patients with acute kidney injury subjected to continuous renal replacement therapies].[接受持续肾脏替代治疗的急性肾损伤患者的抗假单胞菌抗生素剂量]
Med Intensiva. 2013 Apr;37(3):185-200. doi: 10.1016/j.medin.2012.02.012. Epub 2012 Apr 3.

引用本文的文献

1
Drug treatment during continuous haemofiltration.持续血液滤过期间的药物治疗。
Intensive Care Med. 1994;20(2):166. doi: 10.1007/BF01707677.

本文引用的文献

1
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
2
Drug dosing during continuous arteriovenous hemofiltration.持续动静脉血液滤过期间的药物给药
Clin Pharm. 1988 Mar;7(3):198-206.